Medina L. Woodson

Medina L. Woodson serves as the primary procurement lead for the W40M MRC0 West agency under the Department of the Army, responsible for securing critical medical readiness capabilities essential to operational field care. Her role centers on the acquisition of in-vitro diagnostic substances, surgical instruments, sterilization systems, and blood management solutions that enable high-acuity medical support in deployed environments. She manages the full lifecycle of contract actions—from requirements validation through award and performance monitoring—ensuring alignment with Army medical doctrine and readiness standards. Her portfolio is strategically focused on technologies that sustain diagnostic sovereignty and laboratory autonomy in austere settings. Woodson maintains consistent, long-term partnerships with leading medical technology providers, including Roche Diagnostics Corporation, Abbott Molecular Inc., Cardinal Health 414, LLC, Surgical Neuromonitoring Associates, Inc., and Premier Shockwave, Inc. These relationships are built on the procurement of clinically validated, FDA-registered medical devices and reagents requiring stringent regulatory compliance and supply chain resilience. Her contracting approach emphasizes performance-based specifications, technical interoperability, and rapid logistics integration, ensuring field-deployable solutions meet the Army’s demanding operational tempo. Her contracting patterns reflect a strong preference for open competition, with 95.7% of awards issued under no set-aside authority, indicating a focus on technical capability and mission necessity over socioeconomic preferences. Only 4.3% of awards are designated as total small business set-asides under FAR 19.5, suggesting a selective but deliberate engagement with qualified small vendors when their technical offerings align with niche requirements. The agency’s procurement activity is overwhelmingly concentrated in NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing), reflecting deep expertise in molecular diagnostics, assay reagents, and point-of-care testing platforms. Secondary focus areas include blood and organ banking (621991) and analytical laboratory instrument manufacturing (334516), underscoring Woodson’s technical proficiency in advanced medical diagnostics and transfusion medicine systems critical to combat casualty care.